Home › Lymphangioleiomyomatosis
Lymphangioleiomyomatosis clinical trials recruiting in the U.S.
6 studies for Lymphangioleiomyomatosis are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
Study of the Disease Process of Lymphangioleiomyomatosis
RecruitingObservational study
Ages 16 to 100 · All sexes · Updated Sep 28, 2026 · NCT00001465Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
RecruitingPhase 1/2
Ages 18 to 100 · Women · Updated Aug 31, 2026 · NCT01799538TSC Biosample Repository and Natural History Database
RecruitingObservational study
All ages · All sexes · Updated Jun 24, 2026 · NCT05676099Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)
RecruitingObservational study
All ages · Women · Updated Jan 23, 2026 · NCT06160310Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM)
RecruitingPhase 1
Ages 18 to 64 · Women · Updated Jan 21, 2026 · NCT06889168Safety and Durability of Sirolimus for Treatment of LAM
RecruitingObservational study
Ages 18 and older · Women · Updated Dec 24, 2024 · NCT02432560From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.